Global Mass Spectrometry Imaging Market By Types (MALDI, ESI and Other Types), By Application (Proteomics, Clinical, Metabolomics) and By Region - Global Forecast 2030

Global Mass Spectrometry Imaging Market Overview:

The Global Mass Spectrometry Imaging Market was valued at UЅD $708.1 Мn in 2020, and is projected to achieve a valuation of UЅD $1,298.0 Мn by 2030, at a САGR of 7.4%.

Mass spectrometry imaging is a technique used in mass spectrometry to visualize the spatial distribution of molecules, as biomarkers, peptides, metabolites, or proteins by their respective molecular masses.

Dynamics:

The increasing need to obtain vital information about new biomarkers through the process of mass spectrometry is a major factor that is anticipated to continue to fuel the revenue growth of the global mass spectrometry imaging market over the next 10 years.

Moreover, the pivotal role that mass spectrometry imaging plays when implemented by oncologist researchers to identify the structure of cancerous cells and the various genetic alterations that may occur within them, in order for them to effective carry out targeted experiments. This is also a factor that is slated to have a profound impact on the future market growth opportunities for this global industry.

Furthermore, the ability for the mass spectrometry imaging process to easily capture and analyze various molecular elements within a single species, allowing researchers greater insights into cellular behaviors and their corresponding responses to the various drugs being administered, which otherwise would not be possible using conventional methods, is also a factor that is expected to augment revenue growth opportunities for the global mass spectrometry imaging market over the forecast period.

However, in light of the recent COVID-19 outbreak, the operations of numerous industries have either been temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies.

The global mass spectrometry imaging market is no different, and this factor is anticipated to have an immensely negative impact on the revenue growth of this industry. Moreover, the high cost of mass spectrometry devices is another factor that could potentially restrain the revenue growth of the global mass spectrometry imaging market in the coming years.

Nonetheless, the increasing focus by key industry players towards markets in various emerging economies across the world is another factor that is expected to have a profound influence on the revenue growth of the global mass spectrometry imaging market over the next decade.

Segmentation of the Global Mass Spectrometry Imaging Market is as follows:

In terms of type, the MALDI segment accounted for the maximum number of revenue shares of the global mass spectrometry imaging market in 2020, and is expected to continue doing so over the forecast period. The ESI segment is also anticipated to index a high CAGR over the next 10 years.

With regards to application, the clinical segment accounted for the highest number of revenue shares of the global mass spectrometry imaging market in 2020, and is anticipated to continue to do so over the next decade. The proteomics segment is also indicative of registering a high CAGR over the forecast period.

Regional Segmentation and Analysis:

North America accounted for the maximum number of revenue shares of the global mass spectrometry imaging market in 2020, and is indicative of remaining this industry’s front-runner over the next decade. The markets in Europe and the Asia Pacific regions accounted for the second-, and third-most number of revenue shares in 2020, and are indicative of retaining their respective market positions over the course of the forecast period.

Segmentation of the Global Mass Spectrometry Imaging Market:

Segmentation by Type:

• MALDI
• ESI
• Other types

Segmentation by Application:

• Proteomics
• Clinical
• Metabolomics

Segmentation by Regions:

• North America
• Europe
• APAC
• Latin America
• MEA